Cargando…

Clinical Application Value of Circulating Cell-free DNA in Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide and a leading cause of cancer-related deaths. Due to late diagnosis, early intrahepatic metastasis and nonresponse to systemic treatments, surgical resection and/or biopsy specimens remain the gold standard for disease stagin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yuyuan, Liu, Zaoqu, Ji, Kun, Li, Xin, Wang, Caihong, Ren, Zhigang, Liu, Yang, Chen, Xinju, Han, Xinwei, Meng, Lingfang, Li, Lifeng, Li, Zhen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Molecular Biosciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511426/ https://www.ncbi.nlm.nih.gov/pubmed/34660697 http://dx.doi.org/10.3389/fmolb.2021.736330

Ejemplares similares

An Integrated Fibrosis Signature for Predicting Survival and Immunotherapy Efficacy of Patients With Hepatocellular Carcinoma
por: Liu, Long, et al.
Publicado: (2021)

Comprehensive Molecular Analyses of a Novel Mutational Signature Classification System with Regard to Prognosis, Genomic Alterations, and Immune Landscape in Glioma
por: Liu, Zaoqu, et al.
Publicado: (2021)

Editorial: Using multi-omics to develop new strategies to improve prognosis and immunotherapy outcomes in cancers
por: Cao, Chenxi, et al.
Publicado: (2023)

Comprehensive analysis of the prognostic value and functions of prefoldins in hepatocellular carcinoma
por: Ke, Shanjia, et al.
Publicado: (2022)

Methylation of cell-free circulating DNA in the diagnosis of cancer
por: Warton, Kristina, et al.
Publicado: (2015)

Determining the Prognostic Value of Spliceosome-Related Genes in Hepatocellular Carcinoma Patients
por: Liu, Jun, et al.
Publicado: (2022)

Prognostic Value and Immunological Role of KIFC1 in Hepatocellular Carcinoma
por: Li, Dan, et al.
Publicado: (2022)

Meta-Analysis of the Diagnostic Value of Cell-free DNA for Renal Cancer
por: Xu, Yipeng, et al.
Publicado: (2021)

The Prognostic Value of Lysine Acetylation Regulators in Hepatocellular Carcinoma
por: Sun, Liying, et al.
Publicado: (2022)

Tumor-Related Methylated Cell-Free DNA and Circulating Tumor Cells in Melanoma
por: Salvianti, Francesca, et al.
Publicado: (2016)

Novel Insights into the Potential Diagnostic Value of Circulating Exosomal IncRNA-Related Networks in Large Artery Atherosclerotic Stroke
por: Zhang, Shuai, et al.
Publicado: (2021)

Hepatocellular carcinoma risk-stratification based on ASGR1 in circulating epithelial cells for cancer interception
por: Roa-Colomo, Amparo, et al.
Publicado: (2022)

Circulating Tumor DNA in Pediatric Cancer
por: Doculara, Louise, et al.
Publicado: (2022)

Evaluation of the cell-free DNA integrity index as a liquid biopsy marker to differentiate hepatocellular carcinoma from chronic liver disease
por: Kumar, Sonu, et al.
Publicado: (2022)

Identification of Prognostic Biomarkers in Patients With Malignant Rhabdoid Tumor of the Kidney Based on mTORC1 Signaling Pathway-Related Genes
por: Zhanghuang, Chenghao, et al.
Publicado: (2022)

Integrating Cycled Enzymatic DNA Amplification and Surface-Enhanced Raman Scattering for Sensitive Detection of Circulating Tumor DNA
por: Miao, Xinxing, et al.
Publicado: (2021)

Perspectives and mechanisms for targeting ferroptosis in the treatment of hepatocellular carcinoma
por: Li, Lanqing, et al.
Publicado: (2022)

Immunological Significance of Prognostic DNA Methylation Sites in Hepatocellular Carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

Molecular Characterization and Clinical Relevance of ALDH2 in Human Cancers
por: Ma, Bo, et al.
Publicado: (2022)

Differentially Expressed Functional LncRNAs in Human Subjects With Metabolic Syndrome Reflect a Competing Endogenous RNA Network in Circulating Extracellular Vesicles
por: Li, Yongxin, et al.
Publicado: (2021)

Clinical Value and Potential Mechanisms of Oxysterol-Binding Protein Like 3 (OSBPL3) in Human Tumors
por: Hao, Na, et al.
Publicado: (2021)

Ferroptosis Regulator Modification Patterns and Tumor Microenvironment Immune Infiltration Characterization in Hepatocellular Carcinoma
por: Liu, Dong-Li, et al.
Publicado: (2022)

Analysis of the Prognostic Value and Gene Expression Mechanism of SHOX2 in Lung Adenocarcinoma
por: Li, Nanhong, et al.
Publicado: (2021)

Six Metabolism Related mRNAs Predict the Prognosis of Patients With Hepatocellular Carcinoma
por: Wu, Xiwen, et al.
Publicado: (2021)

A circulating miR-19b-based model in diagnosis of human breast cancer
por: Zhao, Qian, et al.
Publicado: (2022)

Understanding the P-Loop Conformation in the Determination of Inhibitor Selectivity Toward the Hepatocellular Carcinoma-Associated Dark Kinase STK17B
por: Liu, Chang, et al.
Publicado: (2022)

A DNA Methylation-Based Panel for the Prognosis and Diagnosis of Patients With Breast Cancer and Its Mechanisms
por: Liu, Xiao-Ping, et al.
Publicado: (2020)

Comprehensive Molecular Analyses of a Six-Gene Signature for Predicting Late Recurrence of Hepatocellular Carcinoma
por: Zhang, Yuyuan, et al.
Publicado: (2021)

Identification of a Pyroptosis-Related Prognostic Signature Combined With Experiments in Hepatocellular Carcinoma
por: Li, Huihui, et al.
Publicado: (2022)

Hepatocyte-Specific Knock-Out of Nfib Aggravates Hepatocellular Tumorigenesis via Enhancing Urea Cycle
por: Zhou, Li, et al.
Publicado: (2022)

Cell Division Cycle Associated Genes as Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma
por: Jiang, Shan-Shan, et al.
Publicado: (2021)

Expression of ALG3 in Hepatocellular Carcinoma and Its Clinical Implication
por: Zhao, Zhen, et al.
Publicado: (2022)

Construction and External Validation of a Ferroptosis-Related Gene Signature of Predictive Value for the Overall Survival in Bladder Cancer
por: Liu, Jingchao, et al.
Publicado: (2021)

Prognostic Value of Oral Epstein–Barr Virus DNA Load in Locoregionally Advanced Nasopharyngeal Carcinoma
por: He, Yong-Qiao, et al.
Publicado: (2022)

Comprehensive Analysis of Necroptosis-Related Long Noncoding RNA Immune Infiltration and Prediction of Prognosis in Patients With Colon Cancer
por: Liu, Li, et al.
Publicado: (2022)

Identification of Two Molecular Subtypes of Hepatocellular Carcinoma Based on Dysregulated Immune LncRNAs
por: Lin, Hongsheng, et al.
Publicado: (2021)

Development of TACE Refractoriness Scores in Hepatocellular Carcinoma
por: Chen, Li, et al.
Publicado: (2021)

Angiogenesis-Related Immune Signatures Correlate With Prognosis, Tumor Microenvironment, and Therapeutic Sensitivity in Hepatocellular Carcinoma
por: Yang, Yuan, et al.
Publicado: (2021)

The Pyroptosis-Related Gene Signature Predicts the Prognosis of Hepatocellular Carcinoma
por: Zhang, Shuqiao, et al.
Publicado: (2022)

CLEC3B as a Potential Prognostic Biomarker in Hepatocellular Carcinoma
por: Xie, Xing-Wei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_631qeb08lci9haalsp51qtcvub